36TH LEGISLATURE OF THE VIRGIN ISLANDS
36TH LEGISLATURE OF THE VIRGIN ISLANDS COMMITTEE ON RULES AND JUDICIARY The Honorable Senator Carla J.. Joseph, Chair of Committee Testimony Presented By The Honorable Justa E. Encarnacion, RN, BSN, MBA/HCM Commissioner of Health on Bill No. 36-0105 - An act amending Title 7 Virgin Islands Code, Chapter 13, Subchapter III by prohibiting the possession, sale, or manufacture of tetrahydrocannabinolic acid, delta-6 THC, delta-8 THC, and delta-10 THC products in the Virgin Islands and for other related purposes VIDOH Testimony on Bill No 36-0105 October 9, 2025 2 | P a g e Good day, Honorable Senator Carla J. Joseph, Chair of the Committee on Rules and Judiciary; 1 Vice Chair Senator Kenneth L. Gittens; Committee and non-Committee members; and those of 2 you viewing and listening. I respectfully submit this written testimony on Bill No. 36-0105 for 3 inclusion in the official record of today’s proceedings. 4 I would like to take a moment to highlight the Environmental Health Division team which 5 continues to inspect high-risk businesses with high impact on our community members. …
Download the original document · Plain text (TXT) · Browse the archive · How this archive works
SHA-256 e8f5e90c8e7b48252e19023a3f850bb9467777986933edc7728ff60497d32c7b
Re-using this document
A proceeding of the Legislature of the Virgin Islands, open to the public under 3 V.I.C. § 881, which reaches any committee of any branch of government and permits the news media to publish what it records.
Our description, tagging, arrangement, extracted text and machine transcripts are released under CC0 1.0. We assert nothing about the document itself.
Archive identifier LF-e8f5e90c8e7b
Document text
36TH LEGISLATURE OF THE VIRGIN ISLANDS COMMITTEE ON RULES AND JUDICIARY The Honorable Senator Carla J.. Joseph, Chair of Committee Testimony Presented By The Honorable Justa E. Encarnacion, RN, BSN, MBA/HCM Commissioner of Health on Bill No. 36-0105 - An act amending Title 7 Virgin Islands Code, Chapter 13, Subchapter III by prohibiting the possession, sale, or manufacture of tetrahydrocannabinolic acid, delta-6 THC, delta-8 THC, and delta-10 THC products in the Virgin Islands and for other related purposes VIDOH Testimony on Bill No 36-0105 October 9, 2025 2 | P a g e Good day, Honorable Senator Carla J. Joseph, Chair of the Committee on Rules and Judiciary; 1 Vice Chair Senator Kenneth L. Gittens; Committee and non-Committee members; and those of 2 you viewing and listening. I respectfully submit this written testimony on Bill No. 36-0105 for 3 inclusion in the official record of today’s proceedings. 4 I would like to take a moment to highlight the Environmental Health Division team which 5 continues to inspect high-risk businesses with high impact on our community members. Their 6 dedication to the goal and objectives of the VI Department of Health and more specifically the 7 policies and mandates identified by the Food and Drug Administration (FDA) is admired and 8 appreciated. A big thank you goes out to all of the members of the VIDOH Team for the work they 9 do every day to keep our community healthy and safe. We would like to thank the Honorable 10 Governor Albert Bryan, Jr., and the Honorable Lieutenant Governor Tregenza A. Roach for their 11 continued support of our mission which is "To Reduce Health Risks, Increase Access to Quality Healthcare 12 and Enforce Health Standards." 13 Thank you for the opportunity to submit testify on Bill No. 36-0105 - An act amending Title 7 of 14 the Virgin Islands Code, Chapter 13, Subchapter III by prohibiting the possession, sale, or 15 manufacture of tetrahydrocannabinolic acid (THCA), delta-6 THC, delta-8 THC and delta-10 THC 16 products in the U.S. Virgin Islands and for other related purposes. 17 While delta-9 THC — the primary psychoactive component of cannabis — has long been 18 regulated, other derivatives like delta-6, delta-8, and delta-10 THC are increasingly being 19 marketed and sold as legal alternatives. Many of these products are manufactured synthetically, 20 often using unregulated chemical processes, and can pose serious risks to consumers. 21 Recent reports from the Center for Disease Control and Prevention (CDC) and the FDA 22 underscore the dangers associated with these products, including increased reports of adverse 23 health effects, such as dizziness, confusion, vomiting, and hallucinations, contamination risks 24 from untested manufacturing processes, and accidental poisonings among children and 25 adolescents due to misleading packaging and labeling. The potential for addiction, cognitive 26 impairment, and long-term neurological harm makes proactive legislation essential. 27 The dangers delta-8 and similar derivatives pose to children cannot be overstated. Too often, these 28 products are packaged and marketed to resemble candy, snacks, or soft drinks—deliberately 29 VIDOH Testimony on Bill No 36-0105 October 9, 2025 3 | P a g e designed to entice young people. One moment of accidental ingestion could result in 1 hospitalization or worse. Without clear regulatory frameworks, these products circumvent existing 2 cannabis controls and put our children at considerable risk of early exposure. 3 The Department of Health is fully prepared to implement Bill 36-0105 through our existing 4 regulatory infrastructure and Food Code authority. Our Environmental Health Division currently 5 conducts routine inspections at retail food establishments across the territory, and we will integrate 6 enforcement of this prohibition into these established protocols. Under Food Code Sections 3- 7 202.12 and 3-201.11, we have clear authority to embargo and remove products containing 8 unapproved food additives from retail establishments. 9 The FDA has explicitly classified delta-8 THC as an unapproved food additive, making any food 10 product containing these substances adulterated under federal law. When our inspectors identify 11 delta-8, delta-10, or THCA products during routine inspections, we can immediately issue hold 12 orders under section 8-903.10 and coordinate with the DLCA and the Industrial Hemp 13 Commission for follow-up enforcement actions. This approach requires no additional 14 infrastructure or policy changes. It is simply the application of the established food safety standards 15 to protect Virgin Islands families from products that have generated over 2,300 poison control 16 calls nationwide, with 41% involving children. The Department stands ready to begin enforcement 17 immediately upon passage of this legislation. 18 This legislation recognizes the paramount responsibility we hold: to protect our youngest and most 19 vulnerable. It draws a clear line, ensuring that no economic interest can override the duty to 20 safeguard our children and families. Prevention must come before a crisis. By prohibiting 21 possession, sale, and the manufacture of these substances, if passed, this legislation can reduce 22 youth access, protect brain development, and decrease the likelihood of future dependency issues. 23 Beyond regulation and enforcement, prevention requires responsible advertising and proactive 24 community education. The Department of Health is committed to leading efforts that ensure the 25 public receives accurate, transparent information about the risks associated with hemp-derived 26 intoxicants and all cannabis-related products. 27 28 We call upon industry partners, community organizations, and media outlets to join us in 29 VIDOH Testimony on Bill No 36-0105 October 9, 2025 4 | P a g e rejecting marketing practices that glamorize or misrepresent these substances. Advertisements 1 must never target youth or vulnerable populations, nor should they obscure the 2 potential harm. Instead, messaging should reinforce safe, legal, and responsible use while 3 discouraging misuse. 4 5 Equally important is education. Through school-based programs, public awareness campaigns, 6 and partnerships with healthcare providers, we can equip Virgin Islanders — especially our 7 youth and families — with the knowledge to make informed choices. Education about product 8 labeling, safe storage in the home, and recognition of signs of intoxication will strengthen 9 community resilience and reduce preventable harm. 10 11 In closing, we must continue to foster innovation and economic opportunity, but never at the 12 expense of public health. This bill strikes the right balance: supporting economic development 13 while standing firm against unsafe and unregulated products. Several U.S. jurisdictions, 14 including New York, Colorado, and North Dakota, have already acted to restrict or ban synthetic 15 and semi-synthetic THC derivatives due to similar concerns. Supporting this bill aligns the 16 Virgin Islands with national public health best practices and demonstrates our commitment to 17 evidence-based policymaking. Furthermore, the FDA has not evaluated or approved delta-8, 18 delta-10, or related compounds for safe use in any context. Given the lack of federal oversight, 19 local action is both necessary and urgent. 20 The Virgin Islands Department of Health is committed to protecting the health and well-being of 21 our residents. By supporting Bill No. 36-0105, the Legislature will take a crucial step toward 22 reducing public health risks, protecting our youth from early substance exposure, and ensuring 23 safer, evidence-driven policies around cannabinoid regulation. Our Department is prepared to 24 work together with the Legislature and our partner agencies to build upon the progress made and 25 strengthen our systems. 26 We thank the sponsor of this bill for his proactive leadership and urge the Committee to advance 27 this measure. The VI Department of Health stands ready to work with lawmakers, community 28 partners, and healthcare providers to ensure its effective implementation. 29 VIDOH Testimony on Bill No 36-0105 October 9, 2025 5 | P a g e Madam Chair, Committee and non-committee members, thank you for your time, attention, and 1 unwavering commitment to the health and well-being of our community. Although we are not able 2 to be there in person, we remain fully available to provide any additional information or support 3 as needed. 4